Peripheral Serum From Breast Implant-Exposed Patients Decreases Breast Cancer Cell Viability: Evidence for Immunosurveillance.

IF 4.2 2区 医学 Q1 SURGERY
Puja Jagasia, Mariana Eduardo, Meryl Pearl Franco, Joshua DeYoung, David Dolivo, Seok Hong, Robert Galiano, Susan Clare, Seema Khan, John Y S Kim, Megan E Fracol
{"title":"Peripheral Serum From Breast Implant-Exposed Patients Decreases Breast Cancer Cell Viability: Evidence for Immunosurveillance.","authors":"Puja Jagasia, Mariana Eduardo, Meryl Pearl Franco, Joshua DeYoung, David Dolivo, Seok Hong, Robert Galiano, Susan Clare, Seema Khan, John Y S Kim, Megan E Fracol","doi":"10.1093/asj/sjaf202","DOIUrl":null,"url":null,"abstract":"<p><p>Epidemiologic and preclinical studies suggest a potential protective effect of breast implants against breast cancer, but underlying mechanisms remain unclear. The authors hypothesize that local inflammation after breast implant placement induces immunosurveillence. The authors of this study investigated whether serum from implant-exposed (IE) women reduced breast cancer cell viability compared with implant-naive (IN) women, and whether antibodies mediated this effect. Serum from IE and IN women with high or low antibody levels against estrogen receptor-alpha, mucin-1, or mammaglobin-A was incubated with cancer cell lines overexpressing each antigen (MCF7, T47D, and SKBR3, respectively). 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MTT) assays measured cell viability. Rescue experiments utilized recombinant antigen to neutralize antibodies. Thirty-six patients were enrolled, and 12 samples were used to assess viability for each cell line. Serum with high antibody concentrations reduced cell viability compared with serum with low antibody concentrations across all cell lines. IE serum reduced cell viability compared with IN serum across all cell lines. Rescue experiments reversed differences between high and low antibody serum, as well as between IE and IN serum, implicating antibodies as the mediators of reduced viability. Peripheral serum from IE women decreased breast cancer cell viability compared with IN women, even when matched for the same antibody levels. Antibody neutralization reversed differences. This suggests implant exposure altered antibody function or other serum components. These findings support the hypothesis that the inflammatory response to breast implants may increase breast cancer immunosurveillance, although significantly more work is needed to confirm a mechanism. Level of Evidence: 3 (Therapeutic) For image description, please refer to the figure legend and surrounding text.</p>","PeriodicalId":7728,"journal":{"name":"Aesthetic Surgery Journal","volume":" ","pages":"1062-1067"},"PeriodicalIF":4.2000,"publicationDate":"2026-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Aesthetic Surgery Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/asj/sjaf202","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

Epidemiologic and preclinical studies suggest a potential protective effect of breast implants against breast cancer, but underlying mechanisms remain unclear. The authors hypothesize that local inflammation after breast implant placement induces immunosurveillence. The authors of this study investigated whether serum from implant-exposed (IE) women reduced breast cancer cell viability compared with implant-naive (IN) women, and whether antibodies mediated this effect. Serum from IE and IN women with high or low antibody levels against estrogen receptor-alpha, mucin-1, or mammaglobin-A was incubated with cancer cell lines overexpressing each antigen (MCF7, T47D, and SKBR3, respectively). 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MTT) assays measured cell viability. Rescue experiments utilized recombinant antigen to neutralize antibodies. Thirty-six patients were enrolled, and 12 samples were used to assess viability for each cell line. Serum with high antibody concentrations reduced cell viability compared with serum with low antibody concentrations across all cell lines. IE serum reduced cell viability compared with IN serum across all cell lines. Rescue experiments reversed differences between high and low antibody serum, as well as between IE and IN serum, implicating antibodies as the mediators of reduced viability. Peripheral serum from IE women decreased breast cancer cell viability compared with IN women, even when matched for the same antibody levels. Antibody neutralization reversed differences. This suggests implant exposure altered antibody function or other serum components. These findings support the hypothesis that the inflammatory response to breast implants may increase breast cancer immunosurveillance, although significantly more work is needed to confirm a mechanism. Level of Evidence: 3 (Therapeutic) For image description, please refer to the figure legend and surrounding text.

乳房植入物暴露患者外周血血清降低乳腺癌细胞活力:免疫监测的证据。
流行病学和临床前研究表明,乳房植入物对乳腺癌有潜在的保护作用,但潜在的机制尚不清楚。作者假设乳房植入后的局部炎症诱导免疫监视。本研究的作者调查了植入物暴露(IE)女性的血清是否比未植入物(IN)女性的血清降低了乳腺癌细胞活力,以及抗体是否介导了这种影响。将雌激素受体α、黏液蛋白1或乳腺球蛋白a抗体水平高或低的IE和IN女性血清与过表达每种抗原(分别为MCF7、T47D和SKBR3)的癌细胞培养。3-(4,5-二甲基噻唑-2-基)-2,5-二苯基溴化四唑(MTT)测定细胞活力。救援实验利用重组抗原来中和抗体。36例患者入组,12个样本用于评估每个细胞系的生存能力。在所有细胞系中,与低抗体浓度的血清相比,高抗体浓度的血清降低了细胞活力。与IN血清相比,IE血清降低了所有细胞系的细胞活力。救援实验逆转了高抗体和低抗体血清之间的差异,以及IE和IN血清之间的差异,暗示抗体是降低生存能力的介质。IE女性的外周血清比IN女性的乳腺癌细胞活力降低,即使在匹配相同抗体水平时也是如此。抗体中和逆转了差异。这表明植入物暴露改变了抗体功能或其他血清成分。这些发现支持了乳房植入物的炎症反应可能增加乳腺癌免疫监测的假设,尽管需要更多的工作来证实其机制。证据等级:3(治疗性)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.20
自引率
20.70%
发文量
309
审稿时长
6-12 weeks
期刊介绍: Aesthetic Surgery Journal is a peer-reviewed international journal focusing on scientific developments and clinical techniques in aesthetic surgery. The official publication of The Aesthetic Society, ASJ is also the official English-language journal of many major international societies of plastic, aesthetic and reconstructive surgery representing South America, Central America, Europe, Asia, and the Middle East. It is also the official journal of the British Association of Aesthetic Plastic Surgeons, the Canadian Society for Aesthetic Plastic Surgery and The Rhinoplasty Society.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书